nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

26.09.2017 | Original Article

Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia

verfasst von: R. Kogoj, M. Praprotnik, T. Mrvič, M. Korva, D. Keše

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Two nationwide Mycoplasma pneumoniae epidemics occurred in Slovenia between 2006 and 2016. The aim of this study was to assess which M. pneumoniae genotypes were present in our area during the selected timeframe, whether the origin of the epidemics was monoclonal or polyclonal and whether the proportion between detected genotypes changed over time. We were also interested in the presence of macrolide resistance (MR) and whether it could be linked to specific genotypes. We performed pyrosequencing of the P1 gene and multiple-locus variable-number tandem repeat (VNTR) analysis (MLVA) typing from 872 M. pneumoniae isolates obtained from respiratory tract infections (RTI)-suffering patients. Additionally, isolates were tested for the presence of MR implicated mutations in the 23S rRNA gene. The MLVA typing results revealed that three main genotypes, MLVA-3,5,6,2, MLVA-3,6,6,2 and MLVA-4,5,7,2, were constantly present and occasionally joined by less abundant, short-lived genotypes, which were detected mostly, but not exclusively, during epidemics. We also noticed a switch in abundance from MLVA-3,5,6,2 and MLVA-3,6,6,2, which dominated in the first epidemic (77.0%; 97/126), to MLVA-4,5,7,2 (71.6%; 428/598), which dominated in the second. Similar to this finding, the dominant P1 type also shifted from type 2 to type 1, although a complete P1 type shift was not observed, since both types remained in circulation. MR was detected in 0.8% (7/872) of M. pneumoniae isolates. Our results seem to suggest that MR remains sporadic in Slovenia at this point in time and that both recent epidemics were polyclonal in nature and, possibly, to some extent, fuelled by the P1 type dominance change.

Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP (2017) Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev 30(3):747–809. https://doi.org/10.1128/CMR.00114-16 CrossRefPubMed

Korppi M, Heiskanen-Kosma T, Kleemola M (2004) Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 9(1):109–114. https://doi.org/10.1111/j.1440-1843.2003.00522.x CrossRefPubMed

Waites KB, Talkington DF (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17(4):697–728, table of contents. https://doi.org/10.1128/CMR.17.4.697-728.2004 CrossRefPubMedPubMedCentral

Foy HM, Grayston JT, Kenny GE, Alexander ER, McMahan R (1966) Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 197(11):859–866CrossRefPubMed

Walter ND, Grant GB, Bandy U, Alexander NE, Winchell JM, Jordan HT, Sejvar JJ, Hicks LA, Gifford DR, Alexander NT, Thurman KA, Schwartz SB, Dennehy PH, Khetsuriani N, Fields BS, Dillon MT, Erdman DD, Whitney CG, Moore MR (2008) Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis 198(9):1365–1374. https://doi.org/10.1086/592281 CrossRefPubMed

Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D; European Working Group on Mycoplasma pneumoniae surveillance (2012) Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. Euro Surveill 17(5). pii: 20075

Diaz MH, Benitez AJ, Winchell JM (2015) Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol 53(1):124–130. https://doi.org/10.1128/JCM.02597-14 CrossRefPubMed

Kim EK, Youn YS, Rhim JW, Shin MS, Kang JH, Lee KY (2015) Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years. Korean J Pediatr 58(5):172–177. https://doi.org/10.3345/kjp.2015.58.5.172 CrossRefPubMedPubMedCentral

Yamazaki T, Kenri T (2016) Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol 7:693. https://doi.org/10.3389/fmicb.2016.00693 CrossRefPubMedPubMedCentral

10.

Himmelreich R, Hilbert H, Plagens H, Pirkl E, Li BC, Herrmann R (1996) Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res 24(22):4420–4449CrossRefPubMedPubMedCentral

11.

Atkinson TP, Balish MF, Waites KB (2008) Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 32(6):956–973. https://doi.org/10.1111/j.1574-6976.2008.00129.x CrossRefPubMed

12.

Benitez AJ, Diaz MH, Wolff BJ, Pimentel G, Njenga MK, Estevez A, Winchell JM (2012) Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. J Clin Microbiol 50(11):3620–3626. https://doi.org/10.1128/JCM.01755-12 CrossRefPubMedPubMedCentral

13.

Cousin-Allery A, Charron A, de Barbeyrac B, Fremy G, Skov Jensen J, Renaudin H, Bebear C (2000) Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect 124(1):103–111CrossRefPubMedPubMedCentral

14.

Dorigo-Zetsma JW, Wilbrink B, Dankert J, Zaat SA (2001) Mycoplasma pneumoniae P1 type 1- and type 2-specific sequences within the P1 cytadhesin gene of individual strains. Infect Immun 69(9):5612–5618CrossRefPubMedPubMedCentral

15.

Dumke R, Catrein I, Pirkil E, Herrmann R, Jacobs E (2003) Subtyping of Mycoplasma pneumoniae isolates based on extended genome sequencing and on expression profiles. Int J Med Microbiol 292(7–8):513–525CrossRefPubMed

16.

Pereyre S, Charron A, Renaudin H, Bébéar C, Bébéar CM (2007) First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 45(11):3534–3539. https://doi.org/10.1128/JCM.01345-07 CrossRefPubMedPubMedCentral

17.

Kenri T, Taniguchi R, Sasaki Y, Okazaki N, Narita M, Izumikawa K, Umetsu M, Sasaki T (1999) Identification of a new variable sequence in the P1 cytadhesin gene of Mycoplasma pneumoniae: evidence for the generation of antigenic variation by DNA recombination between repetitive sequences. Infect Immun 67(9):4557–4562PubMedPubMedCentral

18.

Razin S, Jacobs E (1992) Mycoplasma adhesion. J Gen Microbiol 138(3):407–422. https://doi.org/10.1099/00221287-138-3-407 CrossRefPubMed

19.

Jacobs E, Ehrhardt I, Dumke R (2015) New insights in the outbreak pattern of Mycoplasma pneumoniae. Int J Med Microbiol 305(7):705–708. https://doi.org/10.1016/j.ijmm.2015.08.021 CrossRefPubMed

20.

Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz R, Bébéar C (2012) The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One 7(6):e38585. https://doi.org/10.1371/journal.pone.0038585 CrossRefPubMedPubMedCentral

21.

Liu Y, Ye X, Zhang H, Xu X, Wang M (2012) Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis. J Clin Microbiol 50(8):2793–2795. https://doi.org/10.1128/JCM.00678-12 CrossRefPubMedPubMedCentral

22.

Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar CM (2009) Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol 47(4):914–923. https://doi.org/10.1128/JCM.01935-08 CrossRefPubMedPubMedCentral

23.

Chalker VJ, Pereyre S, Dumke R, Winchell J, Khosla P, Sun H, Yan C, Vink C, Bébéar C (2015) International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect 7:37–40. https://doi.org/10.1016/j.nmni.2015.05.005 CrossRefPubMedPubMedCentral

24.

Sun H, Xue G, Yan C, Li S, Cao L, Yuan Y, Zhao H, Feng Y, Wang L, Fan Z (2013) Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One 8(5):e64607. https://doi.org/10.1371/journal.pone.0064607 CrossRefPubMedPubMedCentral

25.

Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, Wang M (2009) Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from shanghai, China. Antimicrob Agents Chemother 53(5):2160–2162. https://doi.org/10.1128/AAC.01684-08 CrossRefPubMedPubMedCentral

26.

Xin D, Mi Z, Han X, Qin L, Li J, Wei T, Chen X, Ma S, Hou A, Li G, Shi D (2009) Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother 53(5):2158–2159. https://doi.org/10.1128/AAC.01563-08 CrossRefPubMedPubMedCentral

27.

Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C (2010) High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 51(2):189–194. https://doi.org/10.1086/653535 CrossRefPubMed

28.

Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, Chiba N, Iwata S, Ubukata K (2012) Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 55(12):1642–1649. https://doi.org/10.1093/cid/cis784 CrossRefPubMed

29.

Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, Quarto M, Cardinale F (2011) Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother 66(4):734–737. https://doi.org/10.1093/jac/dkr003 CrossRefPubMed

30.

Wolff BJ, Thacker WL, Schwartz SB, Winchell JM (2008) Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 52(10):3542–3549. https://doi.org/10.1128/AAC.00582-08 CrossRefPubMedPubMedCentral

31.

Dumke R, von Baum H, Lück PC, Jacobs E (2010) Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 16(6):613–616. https://doi.org/10.1111/j.1469-0691.2009.02968.x CrossRefPubMed

32.

Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell JM (2015) Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis 2(3):ofv106. https://doi.org/10.1093/ofid/ofv106 CrossRefPubMedPubMedCentral

33.

Spuesens EB, Meijer A, Bierschenk D, Hoogenboezem T, Donker GA, Hartwig NG, Koopmans MP, Vink C, van Rossum AM (2012) Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J Clin Microbiol 50(6):1999–2004. https://doi.org/10.1128/JCM.00400-12 CrossRefPubMedPubMedCentral

34.

Kogoj R, Mrvic T, Praprotnik M, Kese D (2015) Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Euro Surveill 20(37). https://doi.org/10.2807/1560-7917.ES.2015.20.37.30018

35.

Waites KB, Rikihisa Y, Taylor-Robinson D (2003) Mycoplasma and Ureaplasma. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RM (eds) Manual of clinical microbiology, 8th edn. ASM Press, Washington

36.

Nir-Paz R, Abutbul A, Moses AE, Block C, Hidalgo-Grass C (2012) Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill 17(8). pii: 20095

37.

Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bébéar C (2013) The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin Microbiol Infect 19(4):E212–E217. https://doi.org/10.1111/1469-0691.12107 CrossRefPubMed

38.

Brown RJ, Nguipdop-Djomo P, Zhao H, Stanford E, Spiller OB, Chalker VJ (2016) Mycoplasma pneumoniae epidemiology in England and Wales: a national perspective. Front Microbiol 7:157. doi:https://doi.org/10.3389/fmicb.2016.00157 CrossRefPubMedPubMedCentral

39.

Yan C, Sun H, Zhao H (2016) Latest surveillance data on Mycoplasma pneumoniae infections in children, suggesting a new epidemic occurring in Beijing. J Clin Microbiol 54(5):1400–1401. https://doi.org/10.1128/JCM.00184-16 CrossRefPubMedPubMedCentral

40.

Omori R, Nakata Y, Tessmer HL, Suzuki S, Shibayama K (2015) The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling. Sci Rep 5:14473. https://doi.org/10.1038/srep14473 CrossRefPubMedPubMedCentral

41.

Lind K, Benzon MW, Jensen JS, Clyde WA Jr (1997) A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946–1995. Eur J Epidemiol 13(5):581–586CrossRefPubMed

42.

Kenri T, Okazaki N, Yamazaki T, Narita M, Izumikawa K, Matsuoka M, Suzuki S, Horino A, Sasaki T (2008) Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains. J Med Microbiol 57(Pt 4):469–475. https://doi.org/10.1099/jmm.0.47634-0 CrossRefPubMed

43.

Waller JL, Diaz MH, Petrone BL, Benitez AJ, Wolff BJ, Edison L, Tobin-D’Angelo M, Moore A, Martyn A, Dishman H, Drenzek CL, Turner K, Hicks LA, Winchell JM (2014) Detection and characterization of Mycoplasma pneumoniae during an outbreak of respiratory illness at a university. J Clin Microbiol 52(3):849–853. https://doi.org/10.1128/JCM.02810-13 CrossRefPubMedPubMedCentral

44.

Ho PL, Law PY, Chan BW, Wong CW, To KK, Chiu SS, Cheng VC, Yam WC (2015) Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol 53(11):3560–3564. https://doi.org/10.1128/JCM.01983-15 CrossRefPubMedPubMedCentral

45.

Pereyre S, Renaudin H, Charron A, Bébéar C (2012) Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. Emerg Infect Dis 18(2):343–345. https://doi.org/10.3201/eid1802.111379 CrossRefPubMedPubMedCentral

46.

Chironna M, Loconsole D, De Robertis AL, Morea A, Scalini E, Quarto M, Tafuri S, Germinario C, Manzionna M (2016) Clonal spread of a unique strain of macrolide-resistant Mycoplasma pneumoniae within a single family in Italy. Medicine (Baltimore) 95(11):e3160. https://doi.org/10.1097/MD.0000000000003160 CrossRef

47.

Rhea SK, Cox SW, Moore ZS, Mays ER, Benitez AJ, Diaz MH, Winchell JM; Centers for Disease Control and Prevention (CDC) (2014) Notes from the field: atypical pneumonia in three members of an extended family—South Carolina and north Carolina, July–August 2013. MMWR Morb Mortal Wkly Rep 63(33):734–735PubMed

48.

Edelstein I, Rachina S, Touati A, Kozlov R, Henin N, Bébéar C, Pereyre S (2016) Mycoplasma pneumoniae monoclonal P1 type 2c outbreak, Russia, 2013. Emerg Infect Dis 22(2):348–350. https://doi.org/10.3201/eid2202.151349 CrossRefPubMedPubMedCentral

49.

Eshaghi A, Memari N, Tang P, Olsha R, Farrell DJ, Low DE, Gubbay JB, Patel SN (2013) Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010–2011. Emerg Infect Dis 19(9). https://doi.org/10.3201/eid1909.121466

50.

Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, Wiid Svarrer C (2012) Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill 17(5). pii: 20073

51.

Brown RJ, Macfarlane-Smith L, Phillips S, Chalker VJ (2015) Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. Euro Surveill 20(48):30078. https://doi.org/10.2807/1560-7917.ES.2015.20.48.30078 CrossRefPubMed

52.

Meyer Sauteur PM, Bleisch B, Voit A, Maurer FP, Relly C, Berger C, Nadal D, Bloemberg GV (2014) Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland. Swiss Med Wkly 144:w14041. https://doi.org/10.4414/smw.2014.14041 PubMed

Titel: Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia
verfasst von: R. Kogoj
M. Praprotnik
T. Mrvič
M. Korva
D. Keše
Publikationsdatum: 26.09.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2018
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-017-3106-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis

MRSA prevalence rates detected in a tertiary care hospital in Austria and successful treatment of MRSA positive patients applying a decontamination regime with octenidine

Comparison of MALDI-ToF MS with the Rapidec Carba NP test for the detection of carbapenemase-producing Enterobacteriaceae

A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections

Diagnostic accuracy of fungal identification in histopathology and cytopathology specimens

Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Update Innere Medizin